<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36952147</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-6903</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Neurochemical research</Title><ISOAbbreviation>Neurochem Res</ISOAbbreviation></Journal><ArticleTitle>Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog.</ArticleTitle><Pagination><StartPage>2345</StartPage><EndPage>2349</EndPage><MedlinePgn>2345-2349</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11064-023-03912-0</ELocationID><Abstract><AbstractText>After recovering from the acute phase of coronavirus disease 2019 (COVID-19), many patients struggle with additional symptoms of long COVID during the chronic phase. Among them, the neuropsychiatric manifestations characterized by a short-term memory loss and inability to concentrate are called "brain fog". Recent studies have revealed the involvement of "chronic neuro-inflammation" in the pathogenesis of brain fog following COVID-19 infection. In the COVID-related brain fog, similarly to neurodegenerative disorders caused by neuro-inflammation, brain leukocytes, such as microglia and lymphocytes, are hyperactivated, suggesting the overexpression of delayed rectifier K<sup>+</sup>-channels (Kv1.3) within the cells. In our previous patch-clamp studies, drugs, such as antihistamines, statins, nonsteroidal anti-inflammatory drugs, antibiotics and anti-hypertensive drugs, suppressed the Kv1.3-channel activity and reduced the production of pro-inflammatory cytokines. Additionally, newer generation antihistamines, antibiotics and corticosteroids strongly stabilize mast cells that directly activate microglia in the brain. Taking such pharmacological properties of these commonly used drugs into account, they may be useful in the treatment of COVID-related brain fog, in which the enhanced innate and adaptive immune responses are responsible for the pathogenesis.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kazama</LastName><ForeName>Itsuro</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>School of Nursing, Miyagi University, 1-1 Gakuen, Taiwa-Cho, Kurokawa-Gun, Miyagi, 981-3298, Japan. kazamai@myu.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2218</GrantID><Agency>Salt Science Research Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurochem Res</MedlineTA><NlmUniqueID>7613461</NlmUniqueID><ISSNLinking>0364-3190</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain fog</Keyword><Keyword MajorTopicYN="N">Chronic neuro-inflammation</Keyword><Keyword MajorTopicYN="N">Long COVID (coronavirus disease)</Keyword><Keyword MajorTopicYN="N">Lymphocyte Kv1.3-channels</Keyword><Keyword MajorTopicYN="N">Mast cell stabilizers</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>23</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36952147</ArticleId><ArticleId IdType="pmc">PMC10034247</ArticleId><ArticleId IdType="doi">10.1007/s11064-023-03912-0</ArticleId><ArticleId IdType="pii">10.1007/s11064-023-03912-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Wu Y, Zhong P, Hou B, Liu J, Chen Y, Liu J. A clinical staging proposal of the disease course over time in non-severe patients with coronavirus disease 2019. Sci Rep. 2021;11:10681. doi: 10.1038/s41598-021-90111-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90111-y</ArticleId><ArticleId IdType="pmc">PMC8140110</ArticleId><ArticleId IdType="pubmed">34021206</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway EM, Mackman N, Warren RQ, Wolberg AS, Mosnier LO, Campbell RA, Gralinski LE, Rondina MT, van de Veerdonk FL, Hoffmeister KM, Griffin JH, Nugent D, Moon K, Morrissey JH. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol. 2022;22:639&#x2013;649. doi: 10.1038/s41577-022-00762-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00762-9</ArticleId><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Arish M, Qian W, Narasimhan H, Sun J. COVID-19 immunopathology: from acute diseases to chronic sequelae. J Med Virol. 2023;95:e28122. doi: 10.1002/jmv.28122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28122</ArticleId><ArticleId IdType="pmc">PMC9537925</ArticleId><ArticleId IdType="pubmed">36056655</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou MI, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, Rizos E, Boutati E, Grigoriadis N, Krogias C, Giannopoulos S, Tsiodras S, Gaga M, Tsivgoulis G. Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis. 2022;13:20406223221076890. doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;3496. doi: 10.1016/j.neuron.2022.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K, Lin Y, Prewitt KM, Potter DA. Multidisciplinary approach to brain fog and related persisting symptoms post COVID-19. J Health Serv Psychol. 2022;48:31&#x2013;38. doi: 10.1007/s42843-022-00056-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42843-022-00056-7</ArticleId><ArticleId IdType="pmc">PMC8809226</ArticleId><ArticleId IdType="pubmed">35128461</ArticleId></ArticleIdList></Reference><Reference><Citation>Jegal KH, Yoon J, Kim S, Jang S, Jin YH, Lee JH, Choi SM, Kim TH, Kwon S. Herbal medicines for post-acute sequelae (fatigue or cognitive dysfunction) of SARS-CoV-2 infection: a phase 2 pilot clinical study protocol. Healthcare (Basel). 2022;10:1839. doi: 10.3390/healthcare10101839.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10101839</ArticleId><ArticleId IdType="pmc">PMC9601660</ArticleId><ArticleId IdType="pubmed">36292286</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in long Covid-19. N Engl J Med. 2022;387:1813&#x2013;1815. doi: 10.1056/NEJMcibr2210069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, Msika EF, Queneau M, Farid K, Paquet C. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol. 2022;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsini A, Merrick B, Edgeworth J, Mandal G, Srivastava DP, Vernon AC, Nebbia G, Thuret S, Pariante CM. Neurogenesis is disrupted in human hippocampal progenitor cells upon exposure to serum samples from hospitalized COVID-19 patients with neurological symptoms. Mol Psychiatry. 2022;27:5049&#x2013;5061. doi: 10.1038/s41380-022-01741-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01741-1</ArticleId><ArticleId IdType="pmc">PMC9763123</ArticleId><ArticleId IdType="pubmed">36195636</ArticleId></ArticleIdList></Reference><Reference><Citation>Milan A, Salles P, Pelayo C, Uribe-San-Martin R. Acute to chronic electro-clinical manifestations of neuro-COVID and the long-haul consequences in people with epilepsy: a review. Cureus. 2022;14:e26020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9293262</ArticleId><ArticleId IdType="pubmed">35865450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou JJ, Movassaghi M, Gordy D, Olson MG, Zhang T, Khurana MS, Chen Z, Perez-Rosendahl M, Thammachantha S, Singer EJ, Magaki SD, Vinters HV, Yong WH. Neuropathology of COVID-19 (neuro-COVID): clinicopathological update. Free Neuropathol. 2021;2:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7861505</ArticleId><ArticleId IdType="pubmed">33554218</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur KT, Miller EH, Glendinning MD, et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144:2696&#x2013;2708. doi: 10.1093/brain/awab148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab148</ArticleId><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Troscher AR, Wimmer I, Quemada-Garrido L, Kock U, Gessl D, Verberk SGS, Martin B, Lassmann H, Bien CG, Bauer J. Microglial nodules provide the environment for pathogenic T cells in human encephalitis. Acta Neuropathol. 2019;137:619&#x2013;635. doi: 10.1007/s00401-019-01958-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01958-5</ArticleId><ArticleId IdType="pmc">PMC6426829</ArticleId><ArticleId IdType="pubmed">30663001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama I. Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease. J Physiol Sci. 2015;65:25&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10717717</ArticleId><ArticleId IdType="pubmed">25096892</ArticleId></ArticleIdList></Reference><Reference><Citation>Fordyce CB, Jagasia R, Zhu X, Schlichter LC. Microglia Kv1.3 channels contribute to their ability to kill neurons. J Neurosci. 2005;25:7139&#x2013;7149. doi: 10.1523/JNEUROSCI.1251-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1251-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725234</ArticleId><ArticleId IdType="pubmed">16079396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama I, Baba A, Matsubara M, Endo Y, Toyama H, Ejima Y. Benidipine suppresses in situ proliferation of leukocytes and slows the progression of renal fibrosis in rat kidneys with advanced chronic renal failure. Nephron Exp Nephrol. 2014;128:67&#x2013;79. doi: 10.1159/000368080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000368080</ArticleId><ArticleId IdType="pubmed">25358915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama I. Roles of lymphocyte Kv1.3-channels in gut mucosal immune system: novel therapeutic implications for inflammatory bowel disease. Med Hypotheses. 2015;85:61&#x2013;63. doi: 10.1016/j.mehy.2015.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2015.03.023</ArticleId><ArticleId IdType="pubmed">25847395</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Li G, Guo J, Zhang Z, Zhang S, Zhu Y, Cheng J, Yu L, Ji Y, Tao J. Kv1.3 channel as a key therapeutic target for neuroinflammatory diseases: state of the art and beyond. Front Neurosci. 2019;13:1393. doi: 10.3389/fnins.2019.01393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01393</ArticleId><ArticleId IdType="pmc">PMC6971160</ArticleId><ArticleId IdType="pubmed">31992966</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato Y, Kuwana R, Kazama I. Suppressing leukocyte Kv1.3-channels by commonly used drugs: a novel therapeutic target for schizophrenia? Drug Discov Ther. 2022;16:93&#x2013;95. doi: 10.5582/ddt.2022.01031.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2022.01031</ArticleId><ArticleId IdType="pubmed">35444072</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J Investig Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer L. Lots of long COVID treatment leads, but few are proven. Proc Natl Acad Sci U S A. 2022;119:e2213524119. doi: 10.1073/pnas.2213524119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2213524119</ArticleId><ArticleId IdType="pmc">PMC9456722</ArticleId><ArticleId IdType="pubmed">36048910</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajmone-Cat MA, Bernardo A, Greco A, Minghetti L. Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions. Pharmaceuticals (Basel) 2010;3:1949&#x2013;1965. doi: 10.3390/ph3061949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph3061949</ArticleId><ArticleId IdType="pmc">PMC4033961</ArticleId><ArticleId IdType="pubmed">27713336</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama I, Maruyama Y, Murata Y. Suppressive effects of nonsteroidal anti-inflammatory drugs diclofenac sodium, salicylate and indomethacin on delayed rectifier K+-channel currents in murine thymocytes. Immunopharmacol Immunotoxicol. 2012;34:874&#x2013;878. doi: 10.3109/08923973.2012.666249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08923973.2012.666249</ArticleId><ArticleId IdType="pubmed">22409730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama I, Baba A, Maruyama Y. HMG-CoA reductase inhibitors pravastatin, lovastatin and simvastatin suppress delayed rectifier K(+)-channel currents in murine thymocytes. Pharmacol Rep. 2014;66:712&#x2013;717. doi: 10.1016/j.pharep.2014.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharep.2014.03.002</ArticleId><ArticleId IdType="pubmed">24948077</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito K, Abe N, Toyama H, Ejima Y, Yamauchi M, Mushiake H, Kazama I. Second-generation histamine H1 receptor antagonists suppress delayed rectifier K(+)-channel currents in murine thymocytes. Biomed Res Int. 2019;2019:6261951. doi: 10.1155/2019/6261951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/6261951</ArticleId><ArticleId IdType="pmc">PMC6515180</ArticleId><ArticleId IdType="pubmed">31183371</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba A, Tachi M, Maruyama Y, Kazama I. Suppressive effects of diltiazem and verapamil on delayed rectifier K(+)-channel currents in murine thymocytes. Pharmacol Rep. 2015;67:959&#x2013;964. doi: 10.1016/j.pharep.2015.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharep.2015.01.009</ArticleId><ArticleId IdType="pubmed">26398391</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama I, Maruyama Y. Differential effects of clarithromycin and azithromycin on delayed rectifier K(+)-channel currents in murine thymocytes. Pharm Biol. 2013;51:760&#x2013;765. doi: 10.3109/13880209.2013.764539.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13880209.2013.764539</ArticleId><ArticleId IdType="pubmed">23527897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama I, Tamada T, Tachi M. Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases. Inflamm Res. 2015;64:753&#x2013;765. doi: 10.1007/s00011-015-0855-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-015-0855-4</ArticleId><ArticleId IdType="pubmed">26206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. BioFactors. 2021;47:232&#x2013;241. doi: 10.1002/biof.1726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba A, Tachi M, Maruyama Y, Kazama I. Olopatadine inhibits exocytosis in rat peritoneal mast cells by counteracting membrane surface deformation. Cell Physiol Biochem. 2015;35:386&#x2013;396. doi: 10.1159/000369704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369704</ArticleId><ArticleId IdType="pubmed">25591779</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba A, Tachi M, Ejima Y, Endo Y, Toyama H, Matsubara M, Saito K, Yamauchi M, Miura C, Kazama I. Anti-allergic drugs tranilast and ketotifen dose-dependently exert mast cell-stabilizing properties. Cell Physiol Biochem. 2016;38:15&#x2013;27. doi: 10.1159/000438605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000438605</ArticleId><ArticleId IdType="pubmed">26741745</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori T, Abe N, Saito K, Toyama H, Endo Y, Ejima Y, Yamauchi M, Goto M, Mushiake H, Kazama I. Hydrocortisone and dexamethasone dose-dependently stabilize mast cells derived from rat peritoneum. Pharmacol Rep. 2016;68:1358&#x2013;1365. doi: 10.1016/j.pharep.2016.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharep.2016.09.005</ArticleId><ArticleId IdType="pubmed">27710865</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazama I, Saito K, Baba A, Mori T, Abe N, Endo Y, Toyama H, Ejima Y, Matsubara M, Yamauchi M. Clarithromycin dose-dependently stabilizes rat peritoneal mast cells. Chemotherapy. 2016;61:295&#x2013;303. doi: 10.1159/000445023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000445023</ArticleId><ArticleId IdType="pubmed">27088971</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimura R, Asada A, Aizawa M, Kazama I. Cetirizine more potently exerts mast cell-stabilizing property than diphenhydramine. Drug Discov Ther. 2022;16:245&#x2013;250. doi: 10.5582/ddt.2022.01067.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/ddt.2022.01067</ArticleId><ArticleId IdType="pubmed">36261390</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40:277&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4378521</ArticleId><ArticleId IdType="pubmed">25859123</ArticleId></ArticleIdList></Reference><Reference><Citation>Cespedes MDS, Souza J. Coronavirus: a clinical update of Covid-19. Rev Assoc Med Bras. 1992;2020(66):116&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">32428144</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383:334&#x2013;346. doi: 10.1056/NEJMoa2021680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021680</ArticleId><ArticleId IdType="pmc">PMC7346765</ArticleId><ArticleId IdType="pubmed">32598831</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC, Conti P. COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome? J Biol Regul Homeost Agents. 2020;34:1633&#x2013;1636.</Citation><ArticleIdList><ArticleId IdType="pubmed">33023287</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>